MIG Capital: BioNTech Has Transformed Global View Of German Biotech 'But We Don’t Walk On Water’

After BioNTech, German VC Leader Looks To Next Challenge

 
• By Andrew McConaghie
  
Comirnaty
BioNTech and Pfizer's COVID-19 vaccine Comirnaty has transformed the company's fortunes - and the image of the whole German biotech sector. Credit: Getty Images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip